TMCnet - World's Largest Communications and Technology Community



Colorado Bioscience Companies Reach Financing Record of $1.2B
[December 13, 2017]

Colorado Bioscience Companies Reach Financing Record of $1.2B

Colorado's life science sector raised a record $1.2 billion in 2017. The increases came from early-stage to commercial companies, with a 100% increase in financing compared to the previous year.

Three major financings contributed to the banner year for fundraising, with Clovis Oncology raising $526 million; Array Biopharma, $211 million and SomaLogic, $160 million. All three companies are based in Boulder.

Additionally, a recent PwC report ranked Colorado as 2017's number three state for venture capital investments in life science at $519 million, following California ($6.66 billion) and Massachusetts ($2.79billion). Pennsylvania ($410 million) and New York ($250 million) rounded out the top five spots.

April Giles, President & CEO of Colorado BioScience Association, says:

"The success of our sector's fundraising in 2017 shows investors recognize the critical work our companies are doing to manage disease and improve quality of life for patients. Our record year of financing highlights the innovative work happening in Colorado and the new opportunities for venture capitalists seeking promising opportunities in life science."

Jennifer Jones, Vice President of Colorado BioScience Association, says:

"While the big raises make headlines, we are equally proud of the companies in our sector that landed Advanced Industries Grants, awards and early financing rounds. These funds are critical for our start-up and mid-stage companies as they seek to prove out concepts and move into commercialization. We are committed to supporting our sector's need to access capital as we plan for 2018 and beyond."

Additionally, two Colorado life science companies went public in 2017. miRagen Therapeutics of Boulder and Aytu Bioscience of Englewood began trading on the NASDAQ.

Colorado's more than 720 life science organizations range from those moving from early-stage research and development, through clinical trials and into full-fledged commercialization. Those companies are responsible for close to 600 commercial products developed in Colorado.

Connect with CBSA: Twitter (News - Alert) @COBioscience, Facebook and LinkedIn

About the Colorado BioScience Association

Colorado BioScience Association champions life science. We serve as the hub of Colorado's thriving bioscience sector by connecting innovators to funding, infrastructure, research and talent. From promising young companies to established corporations and institutions, we provide opportunities for networking, education and professional development. We grow the bioscience workforce and lead business expansion policies to advance the industry in our state. CBSA represents more than 350 member organizations, including biotechnology, pharmaceutical, medical device, diagnostic, ag bio and mobile digital health companies, research and academic institutions and service providers. Learn more about us at

[ Back To's Homepage ]

Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments:
Comments about this site:


© 2018 Technology Marketing Corporation. All rights reserved | Privacy Policy